Antiepileptic drug management in patients with seizure disorders

Research output: Contribution to journalArticle

Abstract

Epilepsy is a chronic disorder characterized by recurrent, unprovoked seizure episodes. A seizure is a behavioral alteration produced by abnormal activity of the neurons in the cerebral cortex of the brain. The treatment of the patient with epilepsy depends on the underlying etiology, the type of seizure activity, and the presence of precipitating factors. The initial management must include appropriate patient education and counselling. A significant percentage of patients with epilepsy will require antiepileptic drug therapy to enter a seizure remission, ie, an established period of time seizure-free. The majority of patients who receive antiepileptic drug therapy will experience a marked reduction in seizure tendency. The goal of treatment is to render the individual seizure-free without producing antiepileptic drug toxicity. Monotherapy with a nonsedating antiepileptic drug medication is preferred. Parenteral antiepileptic drug therapy is necessary for treating generalized convulsive status epilepticus. This discussion will focus on the appropriate use of antiepileptic drugs in the management of the adult patient with seizures and epilepsy.

Original languageEnglish (US)
Pages (from-to)154-156+161
JournalHospital Formulary
Volume28
Issue number2
StatePublished - 1993

Fingerprint

Anticonvulsants
Epilepsy
Seizures
Drug Therapy
Precipitating Factors
Status Epilepticus
Patient Education
Drug-Related Side Effects and Adverse Reactions
Cerebral Cortex
Counseling
Neurons
Brain
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Antiepileptic drug management in patients with seizure disorders. / Cascino, Gregory D.

In: Hospital Formulary, Vol. 28, No. 2, 1993, p. 154-156+161.

Research output: Contribution to journalArticle

@article{ad56eac276554772ba8767e4701c96e7,
title = "Antiepileptic drug management in patients with seizure disorders",
abstract = "Epilepsy is a chronic disorder characterized by recurrent, unprovoked seizure episodes. A seizure is a behavioral alteration produced by abnormal activity of the neurons in the cerebral cortex of the brain. The treatment of the patient with epilepsy depends on the underlying etiology, the type of seizure activity, and the presence of precipitating factors. The initial management must include appropriate patient education and counselling. A significant percentage of patients with epilepsy will require antiepileptic drug therapy to enter a seizure remission, ie, an established period of time seizure-free. The majority of patients who receive antiepileptic drug therapy will experience a marked reduction in seizure tendency. The goal of treatment is to render the individual seizure-free without producing antiepileptic drug toxicity. Monotherapy with a nonsedating antiepileptic drug medication is preferred. Parenteral antiepileptic drug therapy is necessary for treating generalized convulsive status epilepticus. This discussion will focus on the appropriate use of antiepileptic drugs in the management of the adult patient with seizures and epilepsy.",
author = "Cascino, {Gregory D}",
year = "1993",
language = "English (US)",
volume = "28",
pages = "154--156+161",
journal = "Formulary",
issn = "1082-801X",
publisher = "Advanstar Communications",
number = "2",

}

TY - JOUR

T1 - Antiepileptic drug management in patients with seizure disorders

AU - Cascino, Gregory D

PY - 1993

Y1 - 1993

N2 - Epilepsy is a chronic disorder characterized by recurrent, unprovoked seizure episodes. A seizure is a behavioral alteration produced by abnormal activity of the neurons in the cerebral cortex of the brain. The treatment of the patient with epilepsy depends on the underlying etiology, the type of seizure activity, and the presence of precipitating factors. The initial management must include appropriate patient education and counselling. A significant percentage of patients with epilepsy will require antiepileptic drug therapy to enter a seizure remission, ie, an established period of time seizure-free. The majority of patients who receive antiepileptic drug therapy will experience a marked reduction in seizure tendency. The goal of treatment is to render the individual seizure-free without producing antiepileptic drug toxicity. Monotherapy with a nonsedating antiepileptic drug medication is preferred. Parenteral antiepileptic drug therapy is necessary for treating generalized convulsive status epilepticus. This discussion will focus on the appropriate use of antiepileptic drugs in the management of the adult patient with seizures and epilepsy.

AB - Epilepsy is a chronic disorder characterized by recurrent, unprovoked seizure episodes. A seizure is a behavioral alteration produced by abnormal activity of the neurons in the cerebral cortex of the brain. The treatment of the patient with epilepsy depends on the underlying etiology, the type of seizure activity, and the presence of precipitating factors. The initial management must include appropriate patient education and counselling. A significant percentage of patients with epilepsy will require antiepileptic drug therapy to enter a seizure remission, ie, an established period of time seizure-free. The majority of patients who receive antiepileptic drug therapy will experience a marked reduction in seizure tendency. The goal of treatment is to render the individual seizure-free without producing antiepileptic drug toxicity. Monotherapy with a nonsedating antiepileptic drug medication is preferred. Parenteral antiepileptic drug therapy is necessary for treating generalized convulsive status epilepticus. This discussion will focus on the appropriate use of antiepileptic drugs in the management of the adult patient with seizures and epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=0027447063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027447063&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027447063

VL - 28

SP - 154-156+161

JO - Formulary

JF - Formulary

SN - 1082-801X

IS - 2

ER -